By Bhanvi Satija and Prerna Bedi July 17 (Reuters) - GSK will halt development of an experimental drug to treat refractory ...

Add Yahoo as a preferred source to see more of our stories on Google. Chronic cough is any cough that lasts for at least 4 weeks in children and 8 weeks in adults. If you can't stop coughing it could ...

Mixed Phase 3 data for camlipixant prompted the British pharma to cease development, making the drug the third from its class ...

GSK shares fell after the U.K. drugmaker said it would stop working on an experimental treatment for chronic cough after ...

The British pharma company will discontinue camlipixant’s late-stage RCC programme, though it will continue the drug’s development in two forms of IBS.

Add Yahoo as a preferred source to see more of our stories on Google. There's also a chance that your cough may be exacerbated by a health issue that's wholly unrelated to your first COVID-19 sickness ...

For only the second time globally, wearable data has been accepted by a major regulator as the primary endpoint in a ...

For adults with a history of depression, chronic cough can increase the risk of recurrent depressive events, a study found. Adults with chronic cough experience a disproportionate burden of depressive ...

Chronic cough, with symptoms lasting more than eight weeks, affects approximately one in 10 adults. Cough is among the most common reasons for seeking medical care in the United States, yet chronic ...

Chronic cough took center stage at the European Respiratory Society (ERS) Congress session titled "Conditions We Are Just Dealing With the Tip of the Iceberg in Primary Care: Frequently Mismanaged ...

About 4% to 10% of the adult population experiences chronic cough — a cough lasting eight weeks or more, or at least four weeks for children. A chronic cough doesn't call for immediate medical ...